News blog

IXICO

  • BY: Andrew Hore |
  • POSTED: 12/08/2019 |

Neuroscience-focused digital data analysis technology developer IXICO has signed two new biopharmaceutical client contracts worth a total of more than £1m.

An ongoing phase III study has been extended and this will add £900,000 to the contract value.

One study has been discontinued following an interim review of data. It will not affect revenue this year, but contracted revenues of £3.5m were expected up until 2025. 

© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

News Blog
All micro news

Northern Bear

Roofing and building services provider Northern Bear directors say they will not accept the 72p a share tender offer from Cedarvale Holdings. 

Continue reading... | 21/10/2019

LiDCO Group

Patient monitoring devices supplier LiDCO increased its product revenues by 10% in the year to July 2019. 

Continue reading... | 21/10/2019

Quoted Micro 14 October 2019

Continue reading... | 14/10/2019

Hague and London Oil

Former Aim company Hague and London Oil reported a decline in revenues in the first half of 2019, but it moved from loss to profit, but this was due to a gain on derivative instruments. 

Continue reading... | 13/10/2019

All micro news

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds